MDM2 and cervical carcinoma: The large 95% prediction intervals in all genetic models suggested a considerably high variation between studies, indicating that the associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk could be found to be significantly changed in future studies.